DNAlytics
" Research projects : contributions to research projects with academics and hospital representatives (-omics data investigations, biomarkers and multi-marker indicators, stratification of populations, predictive models for diagnosis/prognosis, ... Development / production capabilities: internal processes and quality system compatible with ISO.13485 (medical devices). Skills and expertise: data sciences, machine learning and other technologies from artificial intelligence; statistics, bio-IT; model encapsulation into software, mobile apps or web platforms "
Funding: Prestations sub-contracted by lead researchers, or partnerships through regional/EU projects with public funding.
Publication References: Complete list on www.dnalytics.com/publications/ 
Contact : This email address is being protected from spambots. You need JavaScript enabled to view it.

CReSPo & IEE - USL-B
" The pandemic is questioning the evolution of multilateralism with an a priori return of States as first line manager. However, paradoxically the need for a coordinated approach both at the global (UN) and European levels appears crucial. We monitor multilateral regulations in border management and control of mobility during and after the pandemic. "
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

ULB 
" Aim: To describe and understand the consequences of the pandemy in a french-speaking teaching hospital a) on the nursing care b) on the nurse-patient interaction. Methods : qualitative research "
Funding: None
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

FARAH - ULiège 
" We are describing the evolution of the respiratory function after infection using whole-body plethysmography in a hamster model of SARS-CoV-2 pneumonia. Although the tropism of the virus for the upper respiratory tract is well documented, little is known about the pathophysiological mechanisms involved in the impairment of the respiratory function and the development of acute respiratory distress syndrome (ARDS) in some patients. There is a critical need for the development of noninvasive evaluation tools of the respiratory function over the disease course in order to develop therapeutic strategies aiming at specifically improving this function. Plethysmography is a noninvasive method allowing the quantitative evaluation of the lung volume and function. The selected plethysmographic parameters will allow a noninvasive monitoring of the lung function and lesions in the hamster model, permitting the screening of therapeutic molecules aiming at alleviating the...

Read more: Daniel Desmecht, Professor - Mutien Garigliany, Professor

FARAH - ULiège 
" We recently showed that domestic cats can be spontaneously infected by SARS-CoV-2 and develop transient, yet severe, pneumonia. Similar reports in other countries confirmed the susceptibility of cats, ferrets, lions and tigers to the infection. Dogs can get infected but, apparenlty, subclinically. Beside the importance of these findings for veterinarians and animal health, a series of domestic or wild animal species might constitute a reservoir of SARS-CoV-2 and dramatically complicate the "uncontainment" process. Domestic cats, minks, ferrets, hamsters, dogs, tigers and lions were all shown to be naturally or (for some species) experimentally susceptible to SARS-CoV-2 infection. In addition, cats, minks, ferrets and hamsters were shown to be able to efficiently transmit the virus to in-contact animals. Little is known about the actual host range of the virus. It is critically needed to determine which domestic, peri-domestic (especially rodents) and wild animals can...

Read more: Daniel Desmecht, Professor - Mutien Garigliany, Professor

UCLouvain - FNRS
" We developed protocols to measure the interaction between single virus and living cells and monitor the effect of blocking molecule interfering with the virus binding. "
Contact: Dr. David Alsteens UCLouvain/ LIBST This email address is being protected from spambots. You need JavaScript enabled to view it.

Erasme Hospital
" Objectifs : L'épidémie du coronavirus a eu des conséquences délétères sur la santé mentale de la population générale1,2. Aucune étude ne s'est encore penchée sur l'impact psychologique du coronavirus sur les proches des patients ayant été infectés par le covid-19. Cette étude permet de comparer les proches de patients survivants ayant séjourné ou n'ayant pas séjourné en soins intensifs, des proches de patients décédés. Méthodologie : Les familles (N=200) dont le proche a séjourné en soins intensifs ou en unité COVID à l'hôpital Erasme seront contactées par téléphone et invitées à compléter des questionnaires en ligne au minimum 1 mois après la sortie d'hospitalisation de leur proche, ou après son décès, et ensuite 6 mois après la première évaluation. Les variables psychologiques qui seront évaluées sont : (1) la qualité de vie (The Mc Gill Quality of Life Questionnaire), les symptômes anxieux et dépressifs (Hospital Anxiety and Depression Scale, HADS), les...

Read more: Delphine Canivet, PhD

ULB
" Production de visières à destination du personnel soignant en collaboration avec le Fablab ULB et le Your Lab. Plans en open source. - Mise en place d'une carte interactive des entreprises oeuvrant dans la lutte contre le covid-19 en collaboration avec le Fablab de Mons et le Fablab Wapi. Objectif de la carte : la mise en valeur des opérateurs économiques. - prototypage de pièces en 3D à la demande des hôpitaux - Prototypage de parois séparatrices en plexi (plan en open source) "
Contact: Fab-C Fablab Charleroi Métropole This email address is being protected from spambots. You need JavaScript enabled to view it. fablab-charleroi.be faceshield-fabc.be

AEPODIA
" Experts in the early development of drugs and medical devices up to clinical proof-of-concept (from preclinical to Phase 2). Via its network of partners, Aepodia facilitates access to patients and to validated clinical centres throughout Europe. With offices in Belgium and France, Aepodia is a recognized partner for pharmaceutical and biotechnology companies since 2007. "
Contact: www.aepodia.com This email address is being protected from spambots. You need JavaScript enabled to view it.

ULB - Fablab ULB
" A multidisciplinary team at the Fablab ULB (Université Libre de Bruxelles, Belgium) has developed and produced different open-source emergency protective solutions against Covid-19 for hospitals and caregivers. Most of these solutions have been developed within the global fablab network using digital fabrication machines (laser cutter, 3D printers,...) and open-source documentation which allowed other fablabs in the world to develop and produced these solutions locally. Face Protective Masks Face Protective Masks have been developed to protect caregivers from aerosol projection. Thanks to a lot of help (other fablabs, architectural offices, students, volunteers,...), we have produced more than 50 000 Protective Face Shields and distributed them in hospitals and to other caregivers. This project was made in collaboration with Fab-C (Charleroi), fablab Yourlab (Andenne) and the Hospital CHU Saint-Pierre in Brussels and supported by the Michel Crémer Foundation. Swabs...

Read more: Denis Terwagne, Professor - Victor Lévy, Professor - Alain Delchambre, Professor - Nicolas De Coster

USL-B 
" Analyses of current decisions and acts, through a "gender prism" ie as regards differences and inequalities on the basis of sex. "
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

Diagenode SA
" CE marked of Covid assay by RT-QPCR "
Contact: didier. This email address is being protected from spambots. You need JavaScript enabled to view it.

UCB
" (1) UCB has an active contribution to increase local COVID-19 diagnostic testing capabilities (up to 5000 tests/day) (2) UCB has developed a UCB Global fund to understand and address long term effect of COVID19 on vulnerable populations' health " 

ULiège and RevaTis SA (Spin Off)
" The project aims to assess the effects of muscle derived stem cells on a preclinical model of acute respiratory distress syndrome induced by a perfusion of endotoxins. We focused on the modulation of neutrophil excessive activation. RevaTis developped a GMP production of muscle derived Mesenchymal Stem Cells and is authorized to produce clinical batches. The IPCLab (Liege University) developed an ARDS model in pigs. We aim to demonstrate a reduction of the ARDS severity, a reduction of the cytokines storm and a modulation of the excessive activation of neutrophils observed in ARDS. "
Funding: Research grants from Ulg (POC) and FNRS (CURE) are pending. RevaTis supplies muscle derived Stem Cells for R&D projects
Publication References: Sci Rep. 2017 Apr 6;7(1):696. doi: 10.1038/s41598-017-00803-7. From skeletal muscle to stem cells: an innovative and minimally-invasive process for multiple species. Ceusters J, Lejeune JP, Sandersen C, Niesten A...

Read more: Didier Serteyn, Professor - Justine Ceusters, CSO RevaTis - Charlotte Sandersen, Professor

ULB
" I wrote two pieces, one on the difficulty inherent to the evaluation of effects of Covid-19 counter-measures, and one which argues that the crisis calls for a paradigm shift in global health policies towards systemic, preventive, and holitistic health policies "
Publication References: Paul E, Brown GW, Ridde V. COVID-19: time for paradigm shift in the nexus between local, national and global health. BMJ Global Health 2020;5:e002622. Paul E, Ridde V. Évaluer les effets des différentes mesures de lutte contre le Covid-19, mission impossible ? The Conversation, 5 avril 2020 (https://theconversation.com/evaluer-les-effets-des-differentes-mesures-de-lutte-contre-le-covid-19-mission-impossible-135060)
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.